发明授权
- 专利标题： Inhibition of phosphoinositide 3-kinase β
- 专利标题（中）： 磷酸肌醇3激酶β的抑制
-
申请号： US10522777申请日： 2003-08-18
-
公开(公告)号： US07598377B2公开(公告)日： 2009-10-06
- 发明人: Shaun P. Jackson , Alan D. Robertson , Vijaya Kenche , Philip Thompson , Hishani Prabaharan , Karen Anderson , Belinda Abbott , Isaac Goncalves , Warwick Nesbitt , Simone Shoenwaelder , Dilek Saylik
- 申请人： Shaun P. Jackson , Alan D. Robertson , Vijaya Kenche , Philip Thompson , Hishani Prabaharan , Karen Anderson , Belinda Abbott , Isaac Goncalves , Warwick Nesbitt , Simone Shoenwaelder , Dilek Saylik
- 申请人地址： SE Sodertalje
- 专利权人： AstraZeneca AB
- 当前专利权人： AstraZeneca AB
- 当前专利权人地址： SE Sodertalje
- 代理机构： Pepper Hamilton LLP
- 国际申请： PCT/IB03/04177 WO 20030818
- 国际公布： WO2004/016607 WO 20040226
- 主分类号： C07D413/04
- IPC分类号： C07D413/04
摘要：
The present invention relates to selective inhibitors of phosphoinositide (PI) 3-kinase β, use of the selective inhibitors in anti-thrombotic therapy, and a method for screening compounds useful for the new anti-thrombotic therapy by detecting selective inhibitory activity of PI 3-kinase β of the compound. The invention also relates to novel compounds that are inhibitors of PI 3-kinase.
公开/授权文献
- US20060276470A1 Inhibition of phsphoinostide 3-dinase beta 公开/授权日：2006-12-07
信息查询
